logo
  

FDA Approves Quadrivalent Influenza Vaccine Including Children Of Six Months

Seqirus, a business of CSL Limited (CSL.AX), Friday announced that the U.S. Food and Drug Administration approved Flucelvax Quadrivalent, the company's cell-based quadrivalent influenza vaccine, for an expanded age indication for children as young as six months old.

With this approval, Flucelvax Quadrivalent, the first and only cell-based influenza vaccine in the U.S., is now indicated for everyone eligible to receive an influenza vaccine in the U.S.

The expanded age indication is supported by a Phase 3 clinical study demonstrating that Flucelvax Quadrivalent was as safe and immunogenic as a standard quadrivalent seasonal influenza vaccine in children six months to

"As one of the world's largest influenza vaccine manufacturers, we continually seek to apply new technologies and evolve our vaccine portfolio to help address challenges associated with seasonal influenza vaccine effectiveness," said Dave Ross, Vice President, North America Commercial Operations at Seqirus. "The FLUCELVAX QUADRIVALENT expanded age indication for children as young as six months of age now allows all eligible people to receive a differentiated influenza vaccine option."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla Inc. founder and CEO Elon Musk has sold some of his stake in the luxury electric car maker to avoid an emergency sale of its stock in the event of a forceful Twitter deal. Twitter Inc. and Tesla shares were gaining more than 4 percent in the pre-market activity on the NYSE and Nasdaq, respectively, following the news. Meta Platforms Inc., the parent of Facebook, Instagram, and WhatsApp, has added three more new privacy features to WhatsApp in its bid to enhance control and privacy on the popular messaging app. These features will give the user more control over their messages with added interlocking layers of protection. Insurance company Prudential plc reported Wednesday a sharp drop in first-half pre-tax profit. On an after-tax basis, the company recorded a profit, compared to last year's hefty loss, due to the absence of prior year's loss from discontinued operations. Separately, Prudential announced its 2022 first interim dividend of 5.74 US cents per ordinary share, which will be paid on September 27.
Follow RTT